Log in

2019 CGS Call for Awards  

Call for Applications: Canadian Geriatrics Society/Pfizer Continence Research Award

CLOSED

Overview:  Through a collaboration between the Canadian Geriatrics Society (CGS) and Pfizer, the CGS is pleased to announce the creation of an award to support either clinical fellows or residents in training to conduct a relevant research project in the area of urinary incontinence in older persons.  Recipients will be granted up to $10,000 over a 12 month period. There may be more than one recipient. 

Aim and Scope: The aim of this award is to support resident / fellow research projects that promote excellence in urinary continence care for older people.  

Objective: To support research from trainees (Residents/Fellows) in Geriatric Medicine / Care of the Elderly, ideally producing peer reviewed published scholarly work in the field of urinary incontinence.

Eligibility

  • Applicants should be members of the CGS at the time of application.
  • Applicants will be a member of a Canadian residency or training program in either Geriatric Medicine or Care of the Elderly or in a fellowship program after completion of a Geriatric Medicine or Care of Elderly residency.

Eligible proposals:

  • Clinical, translational or interventional trials
  • Outcomes / epidemiological research (pharmacoeconomics / economics / disease management)
  • Secondary analysis of existing data sets
  • Quality improvement and educational scholarship

Any proposal that includes a clinical trial involving human participants must be conducted according to ICH and Health Canada guidelines, and conform to the Declaration of Helsinki regarding human subjects in research.

Ineligible proposals:

  • The award cannot be used for part funding of a larger project unless the portion of the larger project for which the award is made is separate and distinguishable (i.e. will result in a stand-alone publication).
  • Proposals for projects that have received funding from other sources.
  • Studies involving the administration / aiming to support the efficacy of a competitor drug or the use of a generic
  • Projects consisting of fundamental (basic) research will not be considered.

Review criteria

  • Proposals will be reviewed by a panel of no fewer than three members comprised of or appointed by the CGS Awards committee. A medical affairs representative of the sponsor will be a non-voting member of the review panel.
  • Proposals will be evaluated on the following criteria:
  • Scientific merit: potential for contribution of knowledge in the field, relevance
  • Feasibility: proposed design, method and analysis, proposed timelines.

    Guidelines for submission

    An application should be submitted by the resident / Fellow who must have as a supervisor who is an active member of CGS. The supervisor will acknowledge supervision and overall responsibility for the project. Funds will be made available to the supervisor / supervisor’s institution.  

    Applications will include:

    • Project proposal not exceeding 5 single spaced pages (Arial 11pt font).
    • References may be included as an appendix (maximum 30)
    • Applications should be structured as follows:
    1. Statement of the problem
    2. Background / literature review
    3. Research question
    4. Methods / Setting / Population
    5. Analysis plan
    6. Timelines
    7. Project budget with justification
    8. CV of applicant and supervisor (CIHR academic CV)
    • Letter of support from supervisor – this should describe the research environment/facilities available to the applicant making the proposed project feasible.
    • Applications should be made online, addressed to The Awards Committee, Continence Fellowship Award and emailed to: cgs@secretariatcentral.com

    The deadline to receive completed applications is February 12, 2019. Awardees will be notified by March 15, 2018. Award winners are invited to be recognized during the CGS Annual Scientific Meeting in Halifax, May 2-4, 2019.

    Conditions of award:

    • The proposed project must be completed within 12 months of receipt of funding.
    • A no-cost 6 month extension can be applied for in cases of unanticipated delay.
    • Peer reviewed publication of the project should ideally occur not more than 18 months following completion of the project.
    • Award recipients are expected to submit an abstract to the CGS Annual Scientific meeting (and others where applicable/allowable) and to submit their work for publication in peer -reviewed journals. All publications and products of scholarship emanating from the award should be acknowledged as follows:

    Research made possible by the Canadian Geriatrics Society – Pfizer Continence Training Fellowship Award.











    Powered by Wild Apricot Membership Software